MetLife, Inc.
$54.29B- Market cap
- $61.50B
- Debt
- +$14.82B
- Cash
- −$22.03B
Capital structure 81% equity / 19% debt · EV / Revenue 0.70x · EV proxy / EBITDA proxy 8.57x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MET stock price at premium vs HIG $96.78 current versus $48.37 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HIG's multiple
Implied fair value · at MET's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Higher P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 81% equity / 19% debt · EV / Revenue 0.70x · EV proxy / EBITDA proxy 8.57x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MetLife, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
The Hartford Insurance Group, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MET can sustain its high ROIC (33.7%) and narrow the margin gap with peers, then consider buying because the stock is only 1.7% above HIG-implied P/E price ($77.51) and sits comfortably within its historical band ($70.99 - $86.77), limiting near-term downside while offering upside if operational improvements materialize.
MetLife's current price ($78.88) is essentially in line with HIG-implied valuation ($77.51), showing a modest 1.7% downside on HIG P/E basis. Valuation signals are mixed: similar P/E multiples (13.3x vs 13.0x) but materially different revenue and enterprise multiples, leaving limited near-term upside against HIG-implied midpoint but a wide HIG-implied range.
Supporting Metrics